BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12735792)

  • 21. "Stealth" melanoma cells in histology-negative sentinel lymph nodes.
    Itakura E; Huang RR; Wen DR; Cochran AJ
    Am J Surg Pathol; 2011 Nov; 35(11):1657-65. PubMed ID: 21997686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma.
    Lohmann CM; Iversen K; Jungbluth AA; Berwick M; Busam KJ
    Am J Surg Pathol; 2002 Oct; 26(10):1351-7. PubMed ID: 12360050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful?
    Karimipour DJ; Lowe L; Su L; Hamilton T; Sondak V; Johnson TM; Fullen D
    J Am Acad Dermatol; 2004 May; 50(5):759-64. PubMed ID: 15097961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
    Zubovits J; Buzney E; Yu L; Duncan LM
    Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemistry and sentinel node biopsy in melanoma: the use of tyrosinase and Melan-A.
    Jarrett P; Thomson W; MacKie RM
    Br J Dermatol; 1999 Aug; 141(2):361-2. PubMed ID: 10468824
    [No Abstract]   [Full Text] [Related]  

  • 26. Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry.
    Blaheta HJ; Schittek B; Breuninger H; Maczey E; Kroeber S; Sotlar K; Ellwanger U; Thelen MH; Rassner G; Bültmann B; Garbe C
    Int J Cancer; 1998 Aug; 79(4):318-23. PubMed ID: 9699521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with melanoma.
    Baisden BL; Askin FB; Lange JR; Westra WH
    Am J Surg Pathol; 2000 Aug; 24(8):1140-6. PubMed ID: 10935655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of MART-1, tyrosinase, and SM5-1 in primary and metastatic melanoma.
    Reinke S; Königer P; Herberth G; Audring H; Wang H; Ma J; Guo Y; Sterry W; Trefzer U
    Am J Dermatopathol; 2005 Oct; 27(5):401-6. PubMed ID: 16148409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin.
    Blaheta HJ; Schittek B; Breuninger H; Sotlar K; Ellwanger U; Thelen MH; Maczey E; Rassner G; Bueltmann B; Garbe C
    Am J Surg Pathol; 1999 Jul; 23(7):822-8. PubMed ID: 10403306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel node in melanoma patients: triple negativity with routine techniques and PCR as positive prognostic factor for survival.
    Denninghoff VC; Falco J; Kahn AG; Trouchot V; Curutchet HP; Elsner B
    Mod Pathol; 2008 Apr; 21(4):438-44. PubMed ID: 18223554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes.
    Satzger I; Völker B; Meier A; Schenck F; Kapp A; Gutzmer R
    Am J Surg Pathol; 2007 Aug; 31(8):1175-80. PubMed ID: 17667539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness.
    Blaheta HJ; Paul T; Sotlar K; Maczey E; Schittek B; Paul A; Moehrle M; Breuninger H; Bueltmann B; Rassner G; Garbe C
    Br J Dermatol; 2001 Aug; 145(2):195-202. PubMed ID: 11531779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
    El Shabrawi-Caelen L; Kerl H; Cerroni L
    Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of HMB-45 and anti-Melan A staining of sentinel lymph nodes with isolated positive cells.
    Mahmood MN; Lee MW; Linden MD; Nathanson SD; Hornyak TJ; Zarbo RJ
    Mod Pathol; 2002 Dec; 15(12):1288-93. PubMed ID: 12481009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.
    Spanknebel K; Coit DG; Bieligk SC; Gonen M; Rosai J; Klimstra DS
    Am J Surg Pathol; 2005 Mar; 29(3):305-17. PubMed ID: 15725798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of melanoma micrometastases in sentinel lymph nodes using real-time RT-PCR.
    Giese T; Engstner M; Mansmann U; Hartschuh W; Arden B
    J Invest Dermatol; 2005 Mar; 124(3):633-7. PubMed ID: 15737205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of melanoma mRNA markers in sentinel nodes: pre-clinical evaluation of a single-step real-time reverse transcriptase-polymerase chain reaction assay.
    Abrahamsen HN; Nexo E; Steiniche T; Hamilton-Dutoit SJ; Sorensen BS
    J Mol Diagn; 2004 Aug; 6(3):253-9. PubMed ID: 15269303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.
    Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG
    Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.